Elon Musk’s Neuralink has been given the go-ahead by the US Food and Drug Administration (FDA) to start human trials of its implantable brain-computer interface technology. The device allows people with neurological conditions to communicate with and control devices using their thoughts. Musk aims to one day create “superhuman cognition” with the technology, but its initial use will be to help those with paralysis. The first trials will also demonstrate how Neuralink selects participants from the volunteers who have put themselves forward.
The implant itself is comprised of 64 small, pliable probes that are inserted into the brain, enabling 1,024 two-way channels of communication between the brain and a computer chip. The device can connect wirelessly with external devices, allowing patients to use their minds to connect with smartphones, computers, and other devices. The initial focus of the technology is to restore basic bodily functions in those paralyzed or recovering from spinal cord damage.
Neuralink’s ultimate goal is to develop implants that restore brain function after a heart attack or amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Currently, the company is working on two simultaneous projects: one is targeting the restoration of vision, while the other is designed to restore basic bodily functions for people with paralysis.
Though the specifics of the upcoming human trials have not yet been made public, Musk has previously shared that the FDA had expressed concerns over the device’s lithium battery. Additionally, there had been fears that the implant’s wires could migrate within the brain, or if not securely contained, chemicals could leak into the brain mass.
Musk’s company has faced several federal investigations, including a probe by the US Department of Transportation, which is examining whether the company has violated regulations around transporting dangerous pathogens.
While Musk has previously touted ambitious ideas for Neuralink, including surgical implants to aid with telepathy and obesity, it remains to be seen what restrictions the FDA has placed on Neuralink for the upcoming trials. Nevertheless, the FDA’s approval is seen as a major first step towards the technology one day helping countless individuals suffering from neurological conditions.
This article was generated by AI. We strive to provide the highest quality content possible and value your feedback. Please let us know if you have any concerns or suggestions regarding this article.
